Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope

This study has been terminated.

Sponsored by:	University Hospital, Angers
Information provided by:	University Hospital, Angers
ClinicalTrials.gov Identifier:	NCT00143754

Purpose

Beneficial effect of chronic hydration with salt supplementation in patients with recurrent unexplained syncope is not established. We sought to determine if chronic oral rehydration with salt supplementation improved the tolerance and hemodynamic responses of patients with unexplained recurrent syncope.

Condition	Intervention	Phase
Hydration Loss of Consciousness Neurocardiogenic Syncope	Procedure: Hydration	Phase III

MedlinePlus related topics: Fainting

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Randomized, Single Blind, Uncontrolled, Parallel Assignment
Official Title:	Benefit of Controlled Rehydration in Unexplained Syncope

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Syncopal and/or near syncopal episodes at least twice within the prior 3 months

Exclusion Criteria:

Neurological disease
Structural heart disease
Metabolic and psychiatric illness

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00143754

Sponsors and Collaborators

University Hospital, Angers

Investigators

Principal Investigator:

Georges PN Leftheriotis, MD-PhD

HUAngers

More Information

Study ID Numbers:	CP00-02, Centre Evian pour l'Eau
Study First Received:	August 31, 2005
Last Updated:	August 31, 2005
ClinicalTrials.gov Identifier:	NCT00143754
Health Authority:	France: Ministry of Health

Study placed in the following topic categories:

Signs and Symptoms
Unconsciousness
Consciousness Disorders
Neurologic Manifestations

Neurobehavioral Manifestations
Syncope
Recurrence
Syncope, Vasovagal

Additional relevant MeSH terms:

Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009